Mount Yale Investment Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$499K Buy
2,668
+35
+1% +$6.43K 0.01% 786
2026
Q1
$497K Buy
+2,633
New +$555K 0.01% 721
2025
Q3
– Sell
-1,586
Closed -$279K – 1513
2025
Q2
$279K Buy
+1,586
New +$239K 0.02% 477
2023
Q3
– Sell
-2,929
Closed -$238K – 513
2023
Q2
$238K Sell
2,929
-1,691
-37% -$120K 0.03% 434
2023
Q1
$275K Buy
+4,620
New +$257K 0.03% 401
2022
Q3
– Sell
-5,336
Closed -$280K – 480
2022
Q2
$280K Buy
5,336
+2,162
+68% +$150K 0.04% 370
2022
Q1
$273K Sell
3,174
-928
-23% -$76.2K 0.03% 390
2021
Q4
$335K Sell
4,102
-31
-0.8% -$2.27K 0.03% 348
2021
Q3
$275K Buy
4,133
+20
+0.5% +$1.42K 0.03% 372
2021
Q2
$276K Sell
4,113
-29
-0.7% -$1.8K 0.03% 338
2021
Q1
$215K Buy
+4,142
New +$209K 0.03% 386

Other funds holding THC

Mount Yale Investment Advisors's THC Position: Q2 2026 in Review

Mount Yale Investment Advisors increased its Tenet Healthcare (THC) stake by 1.3% in Q2 2026, buying an estimated $6.43K and bringing the position to 2,668 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #786.

Mount Yale Investment Advisors first reported a position in THC in Q1 2021 and has held it in 11 quarters since. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Mount Yale Investment Advisors held 2,668 shares of Tenet Healthcare worth $499K as of Q2 2026.
  • Mount Yale Investment Advisors bought 35 Tenet Healthcare shares in Q2 2026, an estimated $6.43K.
  • Tenet Healthcare made up 0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #786 holding.
  • Mount Yale Investment Advisors first reported a position in Tenet Healthcare in Q1 2021 and has held it in 11 quarters since.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.